|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 240.80 EUR | +2.12% |
|
+0.75% | +3.79% |
| Capitalization | 7.72B 9.03B 7.16B 6.72B 12.46B 827B 13.35B 82.22B 32.53B 391B 33.85B 33.16B 1,427B | P/E ratio 2025 * |
13.5x | P/E ratio 2026 * | 13x |
|---|---|---|---|---|---|
| Enterprise value | 7.54B 8.82B 7B 6.56B 12.18B 808B 13.04B 80.31B 31.78B 382B 33.06B 32.39B 1,394B | EV / Sales 2025 * |
1.26x | EV / Sales 2026 * | 1.19x |
| Free-Float |
65.33% | Yield 2025 * |
1.81% | Yield 2026 * | 1.91% |
Last Transcript: Ackermans & van Haaren NV
| 1 day | +2.12% | ||
| 1 week | +0.75% | ||
| Current month | +3.79% | ||
| 1 month | +4.06% | ||
| 3 months | +11.79% | ||
| 6 months | +13.69% | ||
| Current year | +3.79% |
| 1 week | 234 | 242.4 | |
| 1 month | 228.6 | 242.4 | |
| Current year | 231.6 | 242.4 | |
| 1 year | 170 | 242.4 | |
| 3 years | 135.7 | 242.4 | |
| 5 years | 124.8 | 242.4 | |
| 10 years | 100.15 | 242.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 48 | - | |
Piet Dejonghe
CEO | Chief Executive Officer | 60 | - |
Tom Bamelis
DFI | Director of Finance/CFO | 59 | 19/11/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 59 | 01/01/2006 | |
| Director/Board Member | 66 | 01/01/1993 | |
Julien Pestiaux
BRD | Director/Board Member | 47 | 23/05/2011 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.12% | +0.75% | +24.64% | +48.18% | 9.03B | ||
| +2.44% | +0.69% | +14.24% | +14.24% | 74.56B | ||
| +2.10% | +8.28% | +32.19% | +223.61% | 70.57B | ||
| +0.08% | -2.46% | +6.63% | +68.83% | 56.57B | ||
| +1.20% | -2.17% | +39.81% | +112.60% | 47.67B | ||
| +1.17% | +9.01% | +116.92% | +880.44% | 40.4B | ||
| +1.77% | -4.67% | +155.87% | +500.89% | 30.87B | ||
| +3.05% | +7.26% | +34.44% | +387.69% | 31.73B | ||
| -1.17% | -1.17% | -9.12% | -8.80% | 30.14B | ||
| +1.89% | -1.17% | +89.86% | +235.93% | 27.69B | ||
| Average | +1.48% | +1.17% | +50.55% | +246.36% | 41.92B | |
| Weighted average by Cap. | +1.51% | +1.52% | +44.54% | +229.33% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 6B 7.01B 5.57B 5.22B 9.69B 643B 10.37B 63.89B 25.28B 304B 26.3B 25.77B 1,109B | 6.09B 7.12B 5.65B 5.3B 9.83B 652B 10.53B 64.84B 25.66B 308B 26.69B 26.15B 1,126B |
| Net income | 574M 672M 533M 500M 927M 61.51B 993M 6.12B 2.42B 29.07B 2.52B 2.47B 106B | 590M 690M 547M 513M 952M 63.17B 1.02B 6.28B 2.49B 29.86B 2.59B 2.53B 109B |
| Net Debt | -179M -209M -166M -156M -289M -19.16B -309M -1.91B -754M -9.06B -785M -768M -33.08B | -487M -569M -452M -424M -786M -52.13B -842M -5.18B -2.05B -24.64B -2.13B -2.09B -90B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/01/26 | 240.80 € | +2.12% | 4,088 |
| 21/01/26 | 235.80 € | -0.25% | 25,839 |
| 20/01/26 | 236.40 € | -1.01% | 24,009 |
| 19/01/26 | 238.80 € | -0.33% | 25,957 |
| 16/01/26 | 239.60 € | -0.83% | 25,392 |
Real-time Euronext Bruxelles, 22 January 2026 at 07:10 pm AEDT
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Annual profits - Rate of surprise
- Stock Market
- Equities
- ACKB Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition

















